Aortech International PLC
7 March 2001
Not for release, publication or distribution in, or into, the United States,
Australia, Canada or Japan or to US persons.
AORTECH INTERNATIONAL PLC
Equity Offering Update
Further to the announcement made by AorTech International plc ('AorTech' or
the 'Company'), on 12 February 2001 of its intention to raise equity capital
through an Open Offer and an International Offering, the Board today announces
that, in light of current market conditions, the Company will not proceed with
an equity offering at this time. The Board also announces that it will not
proceed with its proposed move to the Official List at this time.
The Company is in a position to finance its current business plan. In
addition, the Company will be exploring alternative sources of financing to
secure its long-term growth plans, and will keep equity market conditions
under review.
The EGM convened for 10am on Wednesday, 7 February 2001 will take place,
although resolutions relating to the Open Offer and the International Offering
will not be proposed. However, resolutions concerning a share option scheme
for US employees, amendments to certain provisions of the Company's approved
and unapproved share option plans and to the Articles of Association will be
put to the meeting.
Eddie McDaid, Chief Executive Officer, commented:
'Given the positive response from existing shareholders and the interest shown
from institutional investors in the UK, Continental Europe and the US, we are
clearly disappointed with current market conditions. The Directors and I have
decided that given the tremendous potential of AorTech's technologies, it is
not in the interests of existing shareholders to issue equity at these levels.
The Company will remain focused on achieving its sales targets for truCCOMS
and commercialising its new synthetic Tri-leaflet heart valve and its
Elast-Eon biomaterials.'
7 March 2001
ENQUIRIES:
AorTech International plc Tel: 00 44 (0)1698 746699
Edward McDaid, Chief Executive Officer
Morgan Stanley & Co. International Limited Tel: 00 44 (0)20 7425 5000
Alex Northcott
College Hill Tel: 00 44 (0)20 7457 2020
Michael Padley / Nicholas Nelson
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.